http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2735773-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e704ea18b7d505b1ff94ce67a0d88ebb |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-902 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10 |
| filingDate | 2016-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b85ef3b95629f16f1fe3cdc730637337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da0de416369e2246884d300050714569 |
| publicationDate | 2019-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2735773-T3 |
| titleOfInvention | Manipulated nucleic acids targeting nucleic acids |
| abstract | A composition of two or more manipulated nucleic acid sequences that form a scaffold ("NASC"), the NASC composition comprising: a first manipulated nucleic acid component ("NASC-PC1") comprising, in a 5 'a direction 3 ', a spacer element 1 comprising a nucleic acid target binding sequence 1, a repeat element 1 comprising a repeat nucleic acid sequence 1, and a nucleic acid binding protein binding element 1 comprising a double-stranded nucleic acid binding protein sequence 1, in which the spacer element 1 is covalently connected with the repeating element 1, and the repetition element 1 is covalently connected with the binding element 1 to the nucleic acid binding protein; and a second manipulated nucleic acid component ("NASC-PC2") comprising, in a 5 'to 3' direction, a spacer element 2 comprising a nucleic acid target binding sequence 2, a repeating element 2 comprising a 1C sequence of repeat nucleic acids, and a nucleic acid binding protein 2 comprising a sequence 2 of double chain nucleic acid binding protein, in which the spacer element 2 is covalently connected with the repeating element 2, and the repeating element 2 is covalently connected with the nucleic acid binding protein binding element 2; in which there is a connection between the repeat nucleic acid sequence 1 and the repeat nucleic acid sequence 1C through base pairs with hydrogen bonds, the connection forms the NASC composition, and the NASC composition is able to bind to a first CRISPR-Cas9 Class 2 Type II protein and a second CRISPR-Cas9 Class 2 Type II protein. |
| priorityDate | 2015-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 692.